{"id":"https://openalex.org/W4221069694","doi":"https://doi.org/10.1021/acs.oprd.2c00020","title":"Green Chemistry Articles of Interest to the Pharmaceutical Industry","display_name":"Green Chemistry Articles of Interest to the Pharmaceutical Industry","publication_year":2022,"publication_date":"2022-02-02","ids":{"openalex":"https://openalex.org/W4221069694","doi":"https://doi.org/10.1021/acs.oprd.2c00020"},"language":"en","primary_location":{"id":"doi:10.1021/acs.oprd.2c00020","doi":"https://doi.org/10.1021/acs.oprd.2c00020","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.2c00020","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066158150","display_name":"Marian C. Bryan","orcid":"https://orcid.org/0000-0002-3138-6888","observed_orcids":["https://orcid.org/0000-0002-3138-6888"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marian C. Bryan","raw_affiliation_strings":["Janssen R&D, 1400 McKean Road, Spring House, Pennsylvania 19002, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen R&D, 1400 McKean Road, Spring House, Pennsylvania 19002, United States","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052144055","display_name":"Charlotte E. Dalton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120285","display_name":"CatScI (United Kingdom)","ror":"https://ror.org/01ttqmm87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210120285"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Dalton","raw_affiliation_strings":["CatSci Ltd, CBTC2, Capital Business Park, Cardiff, South Glamorgan CF3 2PX, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CatSci Ltd, CBTC2, Capital Business Park, Cardiff, South Glamorgan CF3 2PX, U.K","institution_ids":["https://openalex.org/I4210120285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053908393","display_name":"Alba D\u00edaz\u2010Rodr\u00edguez","orcid":"https://orcid.org/0000-0001-5707-7998","observed_orcids":["https://orcid.org/0000-0001-5707-7998"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alba D\u00edaz-Rodr\u00edguez","raw_affiliation_strings":["Synthetic Biochemistry, GSK, Gunnels Wood Road, Stevenage SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synthetic Biochemistry, GSK, Gunnels Wood Road, Stevenage SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012350203","display_name":"Jaika Doerfler","orcid":"https://orcid.org/0000-0003-0217-1631","observed_orcids":["https://orcid.org/0000-0003-0217-1631"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaika Doerfler","raw_affiliation_strings":["Drug Substance Technologies, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Substance Technologies, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018533521","display_name":"Oliver D. Engl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver D. Engl","raw_affiliation_strings":["Takeda, 35 Landsdowne Street, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda, 35 Landsdowne Street, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027112304","display_name":"Paul Ferguson","orcid":"https://orcid.org/0000-0001-9098-8056","observed_orcids":["https://orcid.org/0000-0001-9098-8056"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Ferguson","raw_affiliation_strings":["New Modalities Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Modalities Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043346003","display_name":"Alejandro Gimenez Molina","orcid":"https://orcid.org/0000-0003-0037-2704","observed_orcids":["https://orcid.org/0000-0003-0037-2704"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Alejandro Gimenez Molina","raw_affiliation_strings":["Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Antwerpen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Antwerpen, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037011841","display_name":"Zhengxu S. Han","orcid":"https://orcid.org/0000-0001-8386-1356","observed_orcids":["https://orcid.org/0000-0001-8386-1356"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhengxu S. Han","raw_affiliation_strings":["Process Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877, United States"],"raw_orcid":"https://orcid.org/0000-0001-8386-1356","affiliations":[{"raw_affiliation_string":"Process Research, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, Connecticut 06877, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048349714","display_name":"Joseph Hosford","orcid":"https://orcid.org/0000-0002-9259-5309","observed_orcids":["https://orcid.org/0000-0002-9259-5309"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joseph Hosford","raw_affiliation_strings":["Synthetic Biochemistry, GSK, Gunnels Wood Road, Stevenage SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Synthetic Biochemistry, GSK, Gunnels Wood Road, Stevenage SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062510337","display_name":"Gareth P. Howell","orcid":"https://orcid.org/0000-0003-2845-6459","observed_orcids":["https://orcid.org/0000-0003-2845-6459"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gareth P. Howell","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K"],"raw_orcid":"https://orcid.org/0000-0003-2845-6459","affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071082663","display_name":"Marc Hutchby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120285","display_name":"CatScI (United Kingdom)","ror":"https://ror.org/01ttqmm87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210120285"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marc Hutchby","raw_affiliation_strings":["CatSci Ltd, CBTC2, Capital Business Park, Cardiff, South Glamorgan CF3 2PX, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CatSci Ltd, CBTC2, Capital Business Park, Cardiff, South Glamorgan CF3 2PX, U.K","institution_ids":["https://openalex.org/I4210120285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318325","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0002-9522-4474","observed_orcids":["https://orcid.org/0000-0002-9522-4474","https://orcid.org/0000-0003-4136-3409","https://orcid.org/0009-0009-9141-6389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["Novartis, Suzhou Novartis Technical Development Co., Ltd., 18-1 Tonglian Road, Bixi Subdistrict, Changshu, Jiangsu 215537, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, Suzhou Novartis Technical Development Co., Ltd., 18-1 Tonglian Road, Bixi Subdistrict, Changshu, Jiangsu 215537, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055817198","display_name":"Rachel H. Munday","orcid":"https://orcid.org/0000-0002-1774-0529","observed_orcids":["https://orcid.org/0000-0002-1774-0529"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachel H. Munday","raw_affiliation_strings":["Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085760951","display_name":"Antonio Navarro","orcid":"https://orcid.org/0000-0002-3623-0946","observed_orcids":["https://orcid.org/0000-0002-3623-0946"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Navarro","raw_affiliation_strings":["Eli Lilly and Company, Lilly Technology Center, 1400 West Raymond Street, Indianapolis, Indiana 46221, United States"],"raw_orcid":"https://orcid.org/0000-0002-3623-0946","affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Technology Center, 1400 West Raymond Street, Indianapolis, Indiana 46221, United States","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052022705","display_name":"Micha\u00ebl Parmentier","orcid":"https://orcid.org/0000-0002-1732-9641","observed_orcids":["https://orcid.org/0000-0002-1732-9641"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michael Parmentier","raw_affiliation_strings":["Chemical and Analytical Development, Novartis AG, CH-4056 Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-1732-9641","affiliations":[{"raw_affiliation_string":"Chemical and Analytical Development, Novartis AG, CH-4056 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035961037","display_name":"Jan Pawlas","orcid":"https://orcid.org/0000-0002-8151-4112","observed_orcids":["https://orcid.org/0000-0002-8151-4112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan Pawlas","raw_affiliation_strings":["PolyPeptide Group, Limhamnsv\u00e4gen 108, P.O. Box 30089, SE-200 61 Limhamn, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PolyPeptide Group, Limhamnsv\u00e4gen 108, P.O. Box 30089, SE-200 61 Limhamn, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006108649","display_name":"Paul Richardson","orcid":"https://orcid.org/0000-0002-3700-8749","observed_orcids":["https://orcid.org/0000-0002-3700-8749"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul F. Richardson","raw_affiliation_strings":["Pfizer, Chemistry, 10578 Science Center Drive (CB6), San Diego, California 09121, United States"],"raw_orcid":"https://orcid.org/0000-0002-3700-8749","affiliations":[{"raw_affiliation_string":"Pfizer, Chemistry, 10578 Science Center Drive (CB6), San Diego, California 09121, United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029727243","display_name":"William J. Smith","orcid":"https://orcid.org/0000-0003-1569-0799","observed_orcids":["https://orcid.org/0000-0003-1569-0799","https://orcid.org/0000-0002-9692-0850"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William J. Smith","raw_affiliation_strings":["Asymchem Inc., 600 Airport Boulevard, Morrisville, North Carolina 27560, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asymchem Inc., 600 Airport Boulevard, Morrisville, North Carolina 27560, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055300360","display_name":"Alan Steven","orcid":"https://orcid.org/0000-0002-0134-0918","observed_orcids":["https://orcid.org/0000-0002-0134-0918"]},"institutions":[{"id":"https://openalex.org/I4210120285","display_name":"CatScI (United Kingdom)","ror":"https://ror.org/01ttqmm87","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210120285"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Alan Steven","raw_affiliation_strings":["CatSci Ltd, CBTC2, Capital Business Park, Cardiff, South Glamorgan CF3 2PX, U.K"],"raw_orcid":"https://orcid.org/0000-0002-0134-0918","affiliations":[{"raw_affiliation_string":"CatSci Ltd, CBTC2, Capital Business Park, Cardiff, South Glamorgan CF3 2PX, U.K","institution_ids":["https://openalex.org/I4210120285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012398903","display_name":"Balaram S. Takale","orcid":"https://orcid.org/0000-0001-8279-944X","observed_orcids":["https://orcid.org/0000-0001-8279-944X"]},"institutions":[{"id":"https://openalex.org/I67391869","display_name":"Neurocrine Biosciences (United States)","ror":"https://ror.org/05d84mm26","country_code":"US","type":"company","lineage":["https://openalex.org/I67391869"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Balaram S. Takale","raw_affiliation_strings":["Chemical Development, Neurocrine Biosciences, San Diego, California 92130, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemical Development, Neurocrine Biosciences, San Diego, California 92130, United States","institution_ids":["https://openalex.org/I67391869"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061884583","display_name":"Jack A. Terrett","orcid":"https://orcid.org/0000-0001-8777-046X","observed_orcids":["https://orcid.org/0000-0001-8777-046X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack A. Terrett","raw_affiliation_strings":["Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States"],"raw_orcid":"https://orcid.org/0000-0001-8777-046X","affiliations":[{"raw_affiliation_string":"Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069511788","display_name":"Daniel S. Treitler","orcid":"https://orcid.org/0000-0001-5375-4920","observed_orcids":["https://orcid.org/0000-0001-5375-4920"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel S. Treitler","raw_affiliation_strings":["Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States"],"raw_orcid":"https://orcid.org/0000-0001-5375-4920","affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083769463","display_name":"Mingshuo Zeng","orcid":"https://orcid.org/0000-0003-1082-1227","observed_orcids":["https://orcid.org/0000-0003-1082-1227"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mingshuo Zeng","raw_affiliation_strings":["Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5055300360","https://openalex.org/A5066158150"],"corresponding_institution_ids":["https://openalex.org/I4210120285","https://openalex.org/I4405282460"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.4013,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.41901201,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"26","issue":"2","first_page":"251","last_page":"262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10880","display_name":"Environmental Sustainability in Business","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1406","display_name":"Marketing"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10404","display_name":"Enzyme Catalysis and Immobilization","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/green-chemistry","display_name":"green chemistry","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.7609999775886536},{"id":"https://openalex.org/keywords/sustainable-chemical-synthesis","display_name":"sustainable chemical synthesis","score":0.5090000033378601},{"id":"https://openalex.org/keywords/pharmaceutical-manufacturing","display_name":"pharmaceutical manufacturing","score":0.37599998712539673},{"id":"https://openalex.org/keywords/atom-economy","display_name":"atom economy","score":0.44200000166893005},{"id":"https://openalex.org/keywords/green-solvents","display_name":"green solvents","score":0.5099999904632568},{"id":"https://openalex.org/keywords/biocatalysis","display_name":"biocatalysis","score":0.625},{"id":"https://openalex.org/keywords/biodegradable-polymers","display_name":"biodegradable polymers","score":0.41100001335144043},{"id":"https://openalex.org/keywords/biodegradable-packaging","display_name":"biodegradable packaging","score":0.37400001287460327},{"id":"https://openalex.org/keywords/biodegradable-plastics","display_name":"biodegradable plastics","score":0.3930000066757202},{"id":"https://openalex.org/keywords/biodegradable-adhesives","display_name":"biodegradable adhesives","score":0.4950000047683716},{"id":"https://openalex.org/keywords/biodegradable-coatings","display_name":"biodegradable coatings","score":0.4449999928474426},{"id":"https://openalex.org/keywords/biodegradable-films","display_name":"biodegradable films","score":0.4740000069141388},{"id":"https://openalex.org/keywords/biodegradable-textiles","display_name":"biodegradable textiles","score":0.49799999594688416},{"id":"https://openalex.org/keywords/biodegradable-food-packaging","display_name":"biodegradable food packaging","score":0.5609999895095825},{"id":"https://openalex.org/keywords/biodegradable-medical-devices","display_name":"biodegradable medical devices","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.6462997794151306},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6254101395606995},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.3638201355934143},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.3601621985435486},{"id":"https://openalex.org/C126348684","wikidata":"https://www.wikidata.org/wiki/Q3456979","display_name":"Polymer science","level":1,"score":0.34532538056373596},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.329492449760437},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.18524202704429626},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1344413161277771},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.10287943482398987},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.08685246109962463}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acs.oprd.2c00020","doi":"https://doi.org/10.1021/acs.oprd.2c00020","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.2c00020","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research & Development","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3143761869","https://openalex.org/W1976085443","https://openalex.org/W6977326984","https://openalex.org/W2947428935","https://openalex.org/W6912112081","https://openalex.org/W4319782088","https://openalex.org/W2324080322","https://openalex.org/W2949132874","https://openalex.org/W7142318580","https://openalex.org/W2950414036"],"abstract_inverted_index":{"ADVERTISEMENT":[0],"RETURN":[1],"TO":[2],"ISSUEPREVGreen":[3],"Chemistry":[4,6,8],"High...Green":[5],"HighlightsNEXTGreen":[7],"Articles":[9],"of":[10,488,523,549],"Interest":[11],"to":[12,510,515],"the":[13,485,516,521,550,561,574,577,582,589,595],"Pharmaceutical":[14,111,187,245],"IndustryMarian":[15],"C.":[16,18,34],"Bryan*Marian":[17],"BryanJanssen":[19],"R&D,":[20],"1400":[21,268],"McKean":[22],"Road,":[23,60,153,173,229],"Spring":[24],"House,":[25],"Pennsylvania":[26],"19002,":[27],"United":[28,83,99,160,275,325,346,384,404,425,444],"States*Email:":[29],"[email":[30,367],"protected]More":[31,368],"by":[32,50,65,85,101,121,137,162,178,197,215,236,255,277,291,307,327,348,369,386,406,427,446,530],"Marian":[33],"Bryan,":[35],"Charlotte":[36,51],"DaltonCharlotte":[37],"DaltonCatSci":[38],"Ltd,":[39,204,356],"CBTC2,":[40,205,357],"Capital":[41,206,358],"Business":[42,207,359],"Park,":[43,208,360],"Cardiff,":[44,209,361],"South":[45,210,362,399,439],"Glamorgan":[46,211,363],"CF3":[47,212,364],"2PX,":[48,213,365],"U.K.More":[49,64,120,177,196,214,254],"Dalton,":[52],"Alba":[53,66],"D\u00edaz-Rodr\u00edguezAlba":[54],"D\u00edaz-Rodr\u00edguezSynthetic":[55],"Biochemistry,":[56,169],"GSK,":[57,170],"Gunnels":[58,171],"Wood":[59,172],"Stevenage":[61,174],"SG1":[62,175],"2NY,":[63,176],"D\u00edaz-Rodr\u00edguez,":[67],"Jaika":[68,86],"DoerflerJaika":[69],"DoerflerDrug":[70],"Substance":[71],"Technologies,":[72],"Amgen":[73,76],"Inc.,":[74,150,338,395,435],"One":[75],"Center":[77,318],"Drive,":[78,419],"Thousand":[79],"Oaks,":[80],"California":[81,323,382,402,442],"91320,":[82],"StatesMore":[84,100,161,276,326,347,385,405,426,445],"Doerfler,":[87],"Oliver":[88,102],"D.":[89,91,103],"EnglOliver":[90],"EnglTakeda,":[92],"35":[93],"Landsdowne":[94],"Street,":[95,271],"Cambridge,":[96],"Massachusetts":[97],"02139,":[98],"Engl,":[104],"Paul":[105,122,310,328],"FergusonPaul":[106],"FergusonNew":[107],"Modalities":[108],"Product":[109],"Development,":[110,114,186,190,244,248,285,377],"Technology":[112,188,246,266],"&":[113,189,247],"Operations,":[115,191,249],"AstraZeneca,":[116,192,250],"Macclesfield":[117,193,251],"SK10":[118,194,252],"2NA,":[119,195,253],"Ferguson,":[123],"Alejandro":[124,138],"Gimenez":[125,127,139],"MolinaAlejandro":[126],"MolinaJanssen":[128],"Pharmaceutica":[129],"NV,":[130],"Turnhoutseweg":[131],"30,":[132],"B-2340":[133],"Beerse,":[134],"Antwerpen,":[135],"BelgiumMore":[136],"Molina,":[140],"Zhengxu":[141,163],"S.":[142,144,164,373,375,388,411,413,429],"HanZhengxu":[143],"HanProcess":[145],"Research,":[146],"Boehringer":[147],"Ingelheim":[148],"Pharmaceuticals,":[149],"900":[151],"Ridgebury":[152],"P.O.":[154,300],"Box":[155,301],"368,":[156],"Ridgefield,":[157],"Connecticut":[158],"06877,":[159],"Hanhttps://orcid.org/0000-0001-8386-1356,":[165],"Joseph":[166,179],"HosfordJoseph":[167],"HosfordSynthetic":[168],"Hosford,":[180],"Gareth":[181,198],"P.":[182,184,199],"HowellGareth":[183],"HowellChemical":[185],"Howellhttps://orcid.org/0000-0003-2845-6459,":[200],"Marc":[201,216],"HutchbyMarc":[202],"HutchbyCatSci":[203],"Hutchby,":[217],"Wei":[218,237],"LiWei":[219],"LiNovartis,":[220],"Suzhou":[221],"Novartis":[222,286],"Technical":[223],"Development":[224],"Co.,":[225],"Ltd.,":[226],"18-1":[227],"Tonglian":[228],"Bixi":[230],"Subdistrict,":[231],"Changshu,":[232],"Jiangsu":[233],"215537,":[234],"ChinaMore":[235],"Li,":[238],"Rachel":[239,256],"H.":[240,242,257],"MundayRachel":[241],"MundayChemical":[243],"Munday,":[258],"Antonio":[259,278],"NavarroAntonio":[260],"NavarroEli":[261],"Lilly":[262,265],"and":[263,283,431,498,503,532,576,593,609,611,622],"Company,":[264],"Center,":[267],"West":[269],"Raymond":[270],"Indianapolis,":[272],"Indiana":[273],"46221,":[274],"Navarrohttps://orcid.org/0000-0002-3623-0946,":[279],"Michael":[280,292],"ParmentierMichael":[281],"ParmentierChemical":[282],"Analytical":[284],"AG,":[287],"CH-4056":[288],"Basel,":[289],"SwitzerlandMore":[290],"Parmentierhttps://orcid.org/0000-0002-1732-9641,":[293],"Jan":[294,308],"PawlasJan":[295],"PawlasPolyPeptide":[296],"Group,":[297],"Limhamnsv\u00e4gen":[298],"108,":[299],"30089,":[302],"SE-200":[303],"61":[304],"Limhamn,":[305],"SwedenMore":[306],"Pawlas,":[309],"F.":[311,313,329],"RichardsonPaul":[312],"RichardsonPfizer,":[314],"Chemistry,":[315],"10578":[316],"Science":[317],"Drive":[319],"(CB6),":[320],"San":[321,380,400,440],"Diego,":[322,381],"09121,":[324],"Richardsonhttps://orcid.org/0000-0002-3700-8749,":[330],"William":[331,349],"J.":[332,335,350],"Smith":[333],"IIIWilliam":[334],"Smith,":[336,351],"IIIAsymchem":[337],"600":[339],"Airport":[340],"Boulevard,":[341],"Morrisville,":[342],"North":[343],"Carolina":[344],"27560,":[345],"III,":[352],"Alan":[353,370],"Steven*Alan":[354],"StevenCatSci":[355],"U.K.*Email:":[366],"Stevenhttps://orcid.org/0000-0002-0134-0918,":[371],"Balaram":[372,387],"TakaleBalaram":[374],"TakaleChemical":[376],"Neurocrine":[378],"Biosciences,":[379],"92130,":[383],"Takale,":[389],"Jack":[390,407],"A.":[391,393,408],"TerrettJack":[392],"TerrettGenentech":[394],"1":[396,417,436],"DNA":[397,437],"Way,":[398,438],"Francisco,":[401,441],"94080,":[403,443],"Terretthttps://orcid.org/0000-0001-8777-046X,":[409],"Daniel":[410,428],"TreitlerDaniel":[412],"TreitlerBristol":[414],"Myers":[415],"Squibb,":[416],"Squibb":[418],"New":[420,422],"Brunswick,":[421],"Jersey":[423],"08903,":[424],"Treitlerhttps://orcid.org/0000-0001-5375-4920,":[430],"Mingshuo":[432,447],"ZengMingshuo":[433],"ZengGenentech":[434],"ZengCite":[448],"this:":[449],"Org.":[450],"Process":[451],"Res.":[452],"Dev.":[453],"2022,":[454],"26,":[455],"2,":[456,460],"251\u2013262Publication":[457],"Date":[458],"(Web):February":[459],"2022Publication":[461],"History":[462],"Published":[463],"online2":[464],"February":[465,469],"2022Published":[466],"inissue":[467],"18":[468],"2022https://pubs.acs.org/doi/10.1021/acs.oprd.2c00020https://doi.org/10.1021/acs.oprd.2c00020research-articleACS":[470],"PublicationsCopyright":[471],"\u00a9":[472],"2022":[473],"American":[474],"Chemical":[475],"SocietyRequest":[476],"reuse":[477],"permissionsArticle":[478],"Views2884Altmetric-Citations1LEARN":[479],"ABOUT":[480],"THESE":[481],"METRICSArticle":[482],"Views":[483],"are":[484,507,520],"COUNTER-compliant":[486],"sum":[487],"full":[489],"text":[490],"article":[491,555],"downloads":[492],"since":[493],"November":[494],"2008":[495],"(both":[496],"PDF":[497],"HTML)":[499],"across":[500],"all":[501],"institutions":[502],"individuals.":[504],"These":[505],"metrics":[506],"regularly":[508],"updated":[509,533],"reflect":[511],"usage":[512],"leading":[513],"up":[514],"last":[517],"few":[518],"days.Citations":[519],"number":[522],"other":[524],"articles":[525],"citing":[526],"this":[527],"article,":[528],"calculated":[529],"Crossref":[531,539],"daily.":[534],"Find":[535,585],"more":[536,586],"information":[537,587],"about":[538,573],"citation":[540],"counts.The":[541],"Altmetric":[542,590],"Attention":[543,591],"Score":[544,592],"is":[545,597],"a":[546,553,566],"quantitative":[547],"measure":[548],"attention":[551],"that":[552],"research":[554],"has":[556],"received":[557],"online.":[558],"Clicking":[559],"on":[560,588],"donut":[562],"icon":[563],"will":[564],"load":[565],"page":[567],"at":[568],"altmetric.com":[569],"with":[570,605],"additional":[571],"details":[572],"score":[575,596],"social":[578],"media":[579],"presence":[580],"for":[581],"given":[583],"article.":[584],"how":[594],"calculated.":[598],"Share":[599,614],"Add":[600],"toView":[601],"InAdd":[602],"Full":[603],"Text":[604],"ReferenceAdd":[606],"Description":[607],"ExportRISCitationCitation":[608],"abstractCitation":[610],"referencesMore":[612],"Options":[613],"onFacebookTwitterWechatLinked":[615],"InRedditEmail":[616],"Other":[617],"access":[618],"optionsGet":[619],"e-Alertsclose":[620],"SUBJECTS:Alcohols,Anions,Catalysts,Peptides":[621],"proteins,Solvents":[623],"Get":[624],"e-Alerts":[625]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-04-03T00:00:00"}